A Path?

With the CGM being the hottest thing going in diabetes toy land it’s no surprise there is a great deal of interest in what Senseonics is doing. Unlike the Dexcom G6 or the FreeStyle Libre which is worn on the body for either 10 or 14 days, the Eversense system is inserted into the patient’s body and only a transmitter is worn on the outside of the body. Looking through the results the company released yesterday and reading the earnings call transcript we’re wondering about the path forward.

First let’s say there is no question . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

© 2005 - 2019 Diabetic Investor, Inc., all rights reserved. Unless expressly permitted under your written license agreement, you are not authorized to forward or to otherwise copy our newsletter, or any portion thereof, by electronic means or otherwise. 17 U.S.C. §504 provides for statutory damages of up to $150,000 per infringement of a copyright and additional damages.